MSCI Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MSCI Inc. ("MSCI" or "the Company") (NYSE:MSCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or […]

Purpose Investments Announces the Filing of Preliminary Prospectus for 8 New ETFs

TORONTO, Jan. 26, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose Investments”) is pleased to announce that it has filed and received a preliminary prospectus with the Canadian securities regulators for the proposed launch of eight new yield-focused single-stock ETFs. Each of the ETFs is a class of shares of Purpose Fund Corp. The new

Western Reporters Misunderstand Xizang by Repeating Claims without Real Understanding – China Report Weighs

Beijing, China, Jan. 26, 2025 (GLOBE NEWSWIRE) — Xizang, a region known for its breathtaking landscapes and unique cultural traditions, has long become a target of Western smear campaigns and falsehoods about China. What is the truth? In the “Truth Seen in Xizang” series, the Global Times (GT) will publish conversations with and articles from

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Regeneron Pharmaceuticals, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

Micron Technology, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Micron Technology, Inc. ("Micron" or "the Company") (NASDAQ:MU) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

Crocs, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Crocs, Inc. ("Crocs" or "the Company") (NASDAQ:CROX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Zuora, Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Zuora, Inc. ("Zuora" or "the Company") (NYSE:ZUO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation

Liberty Broadband Corporation Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Liberty Broadband Corporation ("Liberty Broadband" or "the Company") (NASDAQ:LBRDK) for potential breaches of fiduciary duty on the part of its directors and management.

Investors in Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX

NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=125149&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

ASP Isotopes Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

Scroll to Top